Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | KC Has Scheduled a Live Webcast on The US Supreme Court Decision on FTC v. Actavis, Inc.The Knowledge Group has scheduled a live webcast entitled: The US Supreme Court Decision on FTC v. Actavis, Inc.: The Legality of Reverse-Payment Settlements of Pharmaceutical Patent Infringement Litigations
By: The Knowledge Group, LLC Event Synopsis: "Reverse-payment" Last year, two closely watched and hotly debated cases at the interface between the patent and antitrust laws were decided by the U.S. Court of Appeals. The Eleventh Circuit in April 2012 in what later became known as FTC v. Actavis, Inc. ("the Androgel case") held that payments made by brand-name patent holders to potential generic entrants in exchange for the latters' delayed market entry in settlement of Paragraph IV litigations were, in effect, per se legal if such settlements fell within the bounds of the so-called "scope of the patent test". Three months later, the Third Circuit in Louisiana Wholesale Drug Co., Inc. v. Merck & Co. et al. ("the K-Dur case II"), in stark conflict with the Eleventh Circuit, held that such settlements are, in effect, presumptively illegal. For further details about this event, please visit: http://www.knowledgecongress.org/ Speakers/Faculty Panel Charles Miller, Senior Counsel, Intellectual Property Law Practice Group, Sills Cummis & Gross P.C. Mark Woodward, Attorney, Federal Trade Commission James Langenfeld, Ph.D., Managing Director, Navigant Economics Professor C. Scott Hemphill, Professor of Law, Columbia University Law School About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Contact information: The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series http://www.knowledgecongress.org info@knowledgecongress.org End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|